← FDA DRUG APPROVALS

FDA ANDA · ANDA085995

PEDIATRIC LTA KIT

Sponsor: HOSPIRA

APPLICATION
ANDA085995
TYPE
ANDA
ORIGINAL APPROVAL
1977-11-17
LATEST ACTION
1993-05-04
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

PEDIATRIC LTA KITDiscontinued
LIDOCAINE HYDROCHLORIDE 2% · SOLUTION · TOPICAL

Approval history

1993-05-04Labeling · Supplement 16AP
1989-06-30Labeling · Supplement 15AP
1989-03-20Manufacturing (CMC) · Supplement 14AP
1986-08-15Manufacturing (CMC) · Supplement 13AP
1985-04-17Manufacturing (CMC) · Supplement 12AP
1983-07-13Manufacturing (CMC) · Supplement 11AP
1983-01-28Manufacturing (CMC) · Supplement 9AP
1977-11-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →